CFG
48
-2
A
41
-3
GIS
34
-3
LH
36
-3
GOOG
87
6
INTU
62
5
MCD
57
-5
TDC
86
2
NSC
39
-11
HCP
52
9
MU
42
7
PFG
33
-3
PEP
41
-6
EA
54
-3
QCOM
55
4
MAR
65
2
PRU
47
-4
ITW
58
-4
TXN
35
2
DD
55
2
CFG
48
-2
A
41
-3
GIS
34
-3
LH
36
-3
GOOG
87
6
INTU
62
5
MCD
57
-5
TDC
86
2
NSC
39
-11
HCP
52
9
MU
42
7
PFG
33
-3
PEP
41
-6
EA
54
-3
QCOM
55
4
MAR
65
2
PRU
47
-4
ITW
58
-4
TXN
35
2
DD
55
2
Financhill
Back

Novonesis (Novozymes) B 10K Form

Sell
49

NVZMY
Novonesis (Novozymes) B

Last Price:
58.89
Seasonality Move:
2.13%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive NVZMY News And Ratings

See the #1 stock for the next 7 days that we like better than NVZMY

NVZMY Financial Statistics

Sales & Book Value

Annual Sales: $2.6B
Cash Flow: $74.9M
Price / Cash Flow: 0
Annual Sales: $7.48
Price / Book: 2.33

Profitability

EPS (TTM): 1.58440
Net Income (TTM): $440.38M
Gross Margin: $1.41B
Return on Equity: 21.49%
Return on Assets: 10.72%

Novonesis (Novozymes) B Earnings Forecast

Key Novonesis (Novozymes) B Financial Ratios

  • The Gross Profit Margin over the past 22 years for NVZMY is 54.32%.
  • The Selling, General & Administrative Expenses for NVZMY have been equal to 18.57% of Gross Profit Margin.
  • The Research & Development expenses have been 11.27% of Revenue.
  • The Interest Expense is 5.72% of Operating Income.
  • The Net Earning history of NVZMY is 16.89% of Total Revenues.
  • Per Share Earnings over the last 22 years have been positive in 17 years.

Novonesis (Novozymes) B Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Chemicals
Sector: Materials
Current Symbol: NVZMY
Website: novozymes.com

Debt

Debt-to-Equity Ratio: 0.53
Current Ratio: 1.3
Quick Ratio: 0.76

Price-to-Earnings

Trailing P/E Ratio: 37.48
Forward P/E Ratio: 0

NVZMY Technical Analysis vs Fundamental Analysis

Sell
49
Novonesis (Novozymes) B (NVZMY) is a Sell

Is Novonesis (Novozymes) B a Buy or a Sell?